Clinical Trials in Ohio

Showing 20081-20100 of 20,938 trials

Evaluate the Onset of Action of SKY0402 Following Local Infiltration in Healthy Volunteers

NCT00806806

Given as a single perioperative injection, SKY0402 could provide adequate, continuous, and extended pain relief that could greatly simplify postoperative pain management, reduce the need for repeated administration, and minimize episodes of breakthrough pain.

Postoperative Pain Management

Pacira Pharmaceuticals, Inc128 participantsStarted Oct 2008

Columbus, Ohio, United States

COMPLETEDPhase 132 miles

Monoclonal Antibody for Treatment of Inhalation Anthrax

NCT00138411

The purpose of this study is to evaluate the safety and pharmacokinetics (how long a drug stays in the bloodstream and how high the levels of the drug are at different times) of ETI-204 following intravenous (IV-into a vein) injections, and to evaluate the effects that ETI-204 may have on the pharmacokinetics of oral (by mouth) ciprofloxacin, an antibiotic approved by the U.S. Food and Drug Administration (FDA). ETI-204 is an experimental drug (not approved by the FDA) intended to protect against anthrax (a bacterial infection). Approximately 36 male and female healthy volunteers ages 18 to 50 will be in this study. Participation in this study may last up to eight weeks. Volunteers will have a single IV dose of the ETI-204 study drug or placebo (inactive substance, and some participants will also receive ciprofloxacin. They will stay in the Clinical Pharmacology Unit at least 36 hours after the dose.

Bacillus Anthracis (Anthrax)

National Institute of Allergy and Infectious Diseases (NIAID)36 participantsStarted Oct 2005

Columbus, Ohio, United States

COMPLETEDPhase 2/350 miles

Dose Ranging Study With LT, Monotherapy, PPAR

NCT00240383

A Randomized, Double-Blind, Dose-Ranging, Dose Comparison-Controlled Trial to Determine the Safety and Efficacy of BMS-298585 in Subjects with Type 2 Diabetes

Diabetes Mellitus II

Bristol-Myers Squibb1,260 participantsStarted May 2002

Anniston, Alabama, United States • Birmingham, Alabama, United States • Huntsville, Alabama, United States +269 more locations

Evaluate the Onset of Action of SKY0402 Following Local Infiltration in Healthy Volunteers

Monoclonal Antibody for Treatment of Inhalation Anthrax

Dose Ranging Study With LT, Monotherapy, PPAR

Find Trials by Condition in Ohio

Study of TRC102 in Combination With Pemetrexed in Cancer Patients

PPAR-COMBO With Sulfonylurea

Fluarix Immunogenicity and Safety Trial

An Open Label SLV308 Safety Extension to Study S308.3.002 in Patients With Parkinson's Disease Experiencing Motor Fluctuations.

Study of AT-101 in Combination With Topotecan in Relapsed/Refractory Small Cell Lung Cancer

A Study of Tadalafil in Men With Benign Prostatic Hyperplasia Symptoms Who Are Being Treated With Alpha Blockers

Neurostimulation to Treat Refractory Angina Pectoris Pain

Ribavirin to Prevent RSV Pneumonia in Bone Marrow Transplant Patients

RexMedical- Option* Vena Cava Filter IDE Study

Cytokine Removal by CRRT in Pediatric Sepsis

Feeding Study in Premature Infants

Comparative Trial of Entecavir Versus Adefovir in the Treatment of Chronic Hepatitis B Infection

Neuropathic Pain in Patients With Cancer

H5 Vaccine Alone or With Adjuvant in Healthy Adults

A Study of Dryvax Vaccine Against Smallpox in Previously Unvaccinated Adults

Study of an External Responsive Neurostimulator System on Epileptiform Activity

Effect of Bazedoxifene, Raloxifene, and Placebo on Breast Density